Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people

Background and Aim:  The aim of this study was to investigate the influence of polygenetic polymorphisms, which play a role in the pathogenesis of metabolic syndrome, on the susceptibility to non‐alcoholic fatty liver disease (NAFLD) of Chinese people. Methods:  The subjects were selected from an ep...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 25; no. 4; pp. 772 - 777
Main Authors Zhou, Yong-Jian, Li, Yu-Yuan, Nie, Yu-Qiang, Yang, Hui, Zhan, Qi, Huang, Jian, Shi, Sheng-Li, Lai, Xiao-Bo, Huang, Hong-Li
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.04.2010
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background and Aim:  The aim of this study was to investigate the influence of polygenetic polymorphisms, which play a role in the pathogenesis of metabolic syndrome, on the susceptibility to non‐alcoholic fatty liver disease (NAFLD) of Chinese people. Methods:  The subjects were selected from an epidemiological survey in the Guangdong province of southern China. In each polymorphism study, 50–117 subjects who met the diagnostic criteria of NAFLD and had typical clinical and ultrasonographic findings were placed into the case group. Using a nested case–control design, the same numbers of matched people without NAFLD were included as controls. Single nucleotide polymorphisms (SNP) at nine positions in seven candidate genes were tested. These SNP were found to be associated with the pathogenesis of metabolic syndrome. Genetic analyses were performed using genomic DNA extracted from peripheral blood leukocytes. Polymerase chain reaction–restriction fragment length polymorphism was applied to detect SNP. Results:  Most candidate genes' SNP were associated with susceptibility to NAFLD. Some showed positive relationships (increased risk): tumor necrosis factor‐α‐238, adiponectin‐45, leptin‐2548, peroxisome proliferator‐activated receptors‐161 and phosphatidyletha‐nolamine N‐methyltransferase‐175. Other SNP demonstrated a negative association (decreased risk): adiponectin‐276 and hepatic lipase‐514. Only two were not associated: tumor necrosis factor‐α‐380 and peroxisome proliferator‐activated receptors‐γ co‐activator‐1α‐482. Conclusion:  Most candidate genes' SNP examined in metabolic syndrome patients were associated with susceptibility to NAFLD.
Bibliography:ArticleID:JGH6144
istex:F4329BAE7A4543D557ABD4BE275BA5E696BF08D8
ark:/67375/WNG-G60JCNMQ-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0815-9319
1440-1746
1440-1746
DOI:10.1111/j.1440-1746.2009.06144.x